Reducing systolic blood pressure to less than 120 mmHg lowered the risk of major cardiovascular events for most people with ...

While coronary heart disease and diabetes are often seen in the same patients, a diagnosis of diabetes does not necessarily mean that patients also have coronary heart disease, according to a new ...

For patients with diabetes, a systolic target of 120 mm Hg led to a significant reduction in CV events in BPROADS, mirroring ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research shows.

Continuous Glucose Monitoring (CGM) is transforming diabetes care in India, where the disease has reached alarming rates.

About 400 people marched to the South African headquarters of Novo Nordisk A/S in Johannesburg this week demanding greater ...

The number of people living with diabetes worldwide has quadrupled in the past two decades, with 830 million people diagnosed ...

Following an impressive data drop this summer highlighting the potential for Eli Lilly’s tirzepatide to stave off progression ...

Real-world data show reduction in use of urate-lowering therapy among people with type 2 diabetes using SGLT2 inhibitors.

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

Nottinghamshire Healthcare’s DESMOND team won the Innovation Award at the recent national Celebrating DESMOND Awards.

Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention.